Salesforce
CRM
Coinbase
COIN
Oracle
ORCL
4
Tesla
TSLA
5
Microsoft
MSFT
US Stock MarketDetailed Quotes
CATX Perspective Therapeutics
- 2.430
- +0.100+4.29%
Close Apr 24 16:00 ET
- 2.430
- 0.0000.00%
Post 16:05 ET
179.94MMarket Cap-1.98P/E (TTM)
2.440High2.280Low1.24MVolume2.360Open2.330Pre Close2.92MTurnover2.28%Turnover RatioLossP/E (Static)74.05MShares19.05052wk High0.62P/B132.22MFloat Cap1.60052wk Low--Dividend TTM54.41MShs Float85.000Historical High--Div YieldTTM6.87%Amplitude0.030Historical Low2.357Avg Price1Lot Size
Perspective Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 50.44%-18.29M | -195.36%-26.61M | 133.29%3.37M | -10.28%-8.9M | 242.43%13.85M | -506.52%-36.91M | -211.59%-9.01M | -610.97%-10.11M | -8.07M | -9.72M |
| Net income from continuing operations | -70.46%-79.28M | -62.79%-40.17M | -46.02%-15.12M | -5.38%-11.7M | -3,211.05%-12.28M | -534.06%-46.51M | -1,087.44%-24.68M | -668.82%-10.36M | ---11.11M | ---371K |
| Operating gains losses | 22.73%27K | -541.67%-77K | 225.00%39K | --63K | -90.91%2K | -92.79%22K | ---12K | --12K | --0 | --22K |
| Depreciation and amortization | 133.87%2.31M | 138.74%721K | 158.30%669K | 132.65%570K | 92.22%346K | 614.49%986K | 364.62%302K | 304.69%259K | --245K | --180K |
| Deferred tax | 20.90%-2.1M | -126.72%-2.1M | --0 | --0 | --0 | ---2.65M | --7.85M | --0 | --0 | ---10.5M |
| Other non cash items | -97.97%93K | -80.46%880K | -850.00%-510K | 25.00%-9K | -1,440.00%-268K | 2,562.37%4.58M | 20,372.73%4.5M | 277.78%68K | ---12K | --20K |
| Change In working capital | 989.52%31.81M | -539.55%-11.44M | 3,105.88%16.35M | 15.26%1.5M | 5,845.70%25.4M | 812.50%2.92M | 346.87%2.6M | -73.25%-544K | --1.3M | ---442K |
| -Change in receivables | -14.65%169K | -227.39%-721K | 78.48%-133K | 241.43%857K | 16,700.00%166K | -19.18%198K | 6.39%566K | -25.35%-618K | --251K | ---1K |
| -Change in inventory | -96.94%11K | --0 | --0 | -200.00%-16K | -78.91%27K | 572.37%359K | 105.09%102K | 34.52%113K | --16K | --128K |
| -Change in prepaid assets | -488.00%-1.91M | -177.74%-936K | -293.00%-882K | 115.84%61K | -156.67%-154K | -30.52%-325K | -400.89%-337K | 3,908.33%457K | ---385K | ---60K |
| -Change in payables and accrued expense | 104.24%5.49M | -533.07%-9.84M | 3,601.41%17.37M | -57.74%601K | -419.25%-2.64M | 572.00%2.69M | 642.16%2.27M | -563.55%-496K | --1.42M | ---509K |
| -Change in other current liabilities | --55K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| -Change in other working capital | --28M | --0 | --0 | --0 | --28M | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 50.44%-18.29M | -195.36%-26.61M | 133.29%3.37M | -10.28%-8.9M | 242.43%13.85M | -506.52%-36.91M | -211.59%-9.01M | -610.97%-10.11M | ---8.07M | ---9.72M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -998.25%-218.93M | -155,632.58%-138.6M | -13,000.00%-29.74M | -475.04%-3.3M | -287.23%-47.3M | 184.51%24.37M | 27.64%-89K | -773.08%-227K | -573K | 25.26M |
| Net PPE purchase and sale | -4,944.68%-54.08M | -15,943.82%-14.28M | -12,989.43%-29.71M | -82.88%-1.02M | -4,413.43%-9.07M | -609.93%-1.07M | 15.24%-89K | -773.08%-227K | ---555K | ---201K |
| Net business purchase and sale | --0 | --0 | --0 | --0 | --0 | --2.7M | --0 | --0 | --0 | --2.7M |
| Net investment purchase and sale | -823.86%-164.78M | ---124.28M | --0 | ---2.28M | -267.92%-38.23M | 200.33%22.76M | --0 | --0 | --0 | --22.76M |
| Net other investing changes | -300.00%-72K | ---48K | ---- | ---- | ---- | 99.70%-18K | --0 | --0 | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -998.25%-218.93M | -155,632.58%-138.6M | -13,000.00%-29.74M | -475.04%-3.3M | -287.23%-47.3M | 184.51%24.37M | 27.64%-89K | -773.08%-227K | ---573K | --25.26M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 36,764.33%289.39M | -1.99%345K | 62,700.00%628K | 23,744.53%122.08M | 208,010.00%166.33M | 2,703.57%785K | 352K | 1K | 512K | -80K |
| Net issuance payments of debt | 29.41%-48K | 0.00%-12K | 23.81%-16K | 60.00%-8K | 20.00%-12K | ---68K | ---12K | ---21K | ---20K | ---15K |
| Net common stock issuance | 75,705.49%275.93M | -6,817.89%-13.14M | 62.09%898K | --235.04M | --53.14M | --364K | ---190K | --554K | --0 | --0 |
| Proceeds from stock option exercised by employees | 2,337.00%13.5M | ---- | ---- | -1,994.74%-10.08M | --10.33M | 1,878.57%554K | ---- | ---- | --532K | --0 |
| Net other financing activities | ---- | ---- | ---- | ---- | 158,353.85%102.87M | ---65K | --0 | --0 | --0 | ---65K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 36,764.33%289.39M | -1.99%345K | 62,700.00%628K | 23,744.53%122.08M | 208,010.00%166.33M | 2,703.57%785K | --352K | --1K | --512K | ---80K |
| Net cash flow | ||||||||||
| Beginning cash position | -55.51%9.42M | 1,146.59%226.44M | 784.83%252.19M | 288.43%142.3M | -55.51%9.42M | -62.24%21.18M | -69.26%18.17M | -52.92%28.5M | --36.63M | --21.18M |
| Current changes in cash | 543.73%52.16M | -1,785.23%-164.86M | -149.06%-25.74M | 1,451.13%109.89M | 759.56%132.88M | 66.32%-11.76M | -190.15%-8.75M | -613.81%-10.34M | ---8.13M | --15.46M |
| End cash Position | 553.72%61.58M | 553.72%61.58M | 1,146.59%226.44M | 784.83%252.19M | 288.43%142.3M | -55.51%9.42M | -83.20%9.42M | -69.26%18.17M | --28.5M | --36.63M |
| Free cash flow | -91.41%-72.71M | -353.12%-41.22M | -154.88%-26.35M | -14.95%-9.92M | 148.13%4.78M | -509.03%-37.99M | -203.64%-9.1M | -613.88%-10.34M | ---8.63M | ---9.92M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call